DE68901931T2 - Zusammensetzungen zur behandlung von gehirn-tumoren. - Google Patents

Zusammensetzungen zur behandlung von gehirn-tumoren.

Info

Publication number
DE68901931T2
DE68901931T2 DE8989301258T DE68901931T DE68901931T2 DE 68901931 T2 DE68901931 T2 DE 68901931T2 DE 8989301258 T DE8989301258 T DE 8989301258T DE 68901931 T DE68901931 T DE 68901931T DE 68901931 T2 DE68901931 T2 DE 68901931T2
Authority
DE
Germany
Prior art keywords
drug
migration
administration
compositions
brain tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989301258T
Other languages
English (en)
Other versions
DE68901931D1 (de
Inventor
Edward E Luck
Dennis M Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matrix Pharmaceutical Inc
Original Assignee
Matrix Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Pharmaceutical Inc filed Critical Matrix Pharmaceutical Inc
Application granted granted Critical
Publication of DE68901931D1 publication Critical patent/DE68901931D1/de
Publication of DE68901931T2 publication Critical patent/DE68901931T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fertilizers (AREA)
DE8989301258T 1988-02-11 1989-02-09 Zusammensetzungen zur behandlung von gehirn-tumoren. Expired - Fee Related DE68901931T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15498488A 1988-02-11 1988-02-11

Publications (2)

Publication Number Publication Date
DE68901931D1 DE68901931D1 (de) 1992-08-06
DE68901931T2 true DE68901931T2 (de) 1992-12-10

Family

ID=22553654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989301258T Expired - Fee Related DE68901931T2 (de) 1988-02-11 1989-02-09 Zusammensetzungen zur behandlung von gehirn-tumoren.

Country Status (7)

Country Link
EP (1) EP0328389B1 (de)
JP (1) JP2862175B2 (de)
AT (1) ATE77754T1 (de)
CA (1) CA1330422C (de)
DE (1) DE68901931T2 (de)
ES (1) ES2045404T3 (de)
GR (1) GR3005841T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5750146A (en) * 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug
DE10037983B4 (de) * 2000-08-03 2006-04-13 Stefan Zikeli Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid
JP2003119156A (ja) * 2001-08-06 2003-04-23 Kikuji Yamashita コラーゲンを含有する口腔用剤、医薬品および医薬部外品
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179753B (en) * 1977-10-13 1982-12-28 Richter Gedeon Vegyeszet Process for producting synergetic pharmaceutical compositions of citostatic activity
US4619913A (en) * 1984-05-29 1986-10-28 Matrix Pharmaceuticals, Inc. Treatments employing drug-containing matrices for introduction into cellular lesion areas

Also Published As

Publication number Publication date
GR3005841T3 (de) 1993-06-07
EP0328389A3 (en) 1989-10-11
EP0328389B1 (de) 1992-07-01
DE68901931D1 (de) 1992-08-06
JP2862175B2 (ja) 1999-02-24
ES2045404T3 (es) 1994-01-16
EP0328389A2 (de) 1989-08-16
ATE77754T1 (de) 1992-07-15
CA1330422C (en) 1994-06-28
JPH021406A (ja) 1990-01-05

Similar Documents

Publication Publication Date Title
DE69806246T3 (de) Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
ATE55258T1 (de) Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen.
ES2058592T3 (es) El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales.
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
ATE20701T1 (de) Perioperative anwendung der elektronischen schmerzlinderung in verbindung mit anaesthesierenden mitteln.
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
ATE202709T1 (de) Zusammensetzungen die g-csf und ein tnf- bindungsprotein enthalten
DE68901931D1 (de) Zusammensetzungen zur behandlung von gehirn-tumoren.
DE69835461D1 (de) Anti-arrhythmische Zusammensetzungen und Behandlungsverfahren
DE69314586T2 (de) Arzneimittelzusammensetzung enthaltend TCF-II
AR006202A1 (es) Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
KR890000108A (ko) 종양 치료용 약제학적 조성물
EA200400348A1 (ru) Цисплатиновые составы пониженной токсичности и способы их применения
NO20000007D0 (no) Anvendelse av veksthormon i sammensetninger til behandling av insulinresistens i hjertet samt for å oeke proteinkinase-B(PKB)- aktivitet
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
KR900017599A (ko) 종양 치료용 약학 조성물
DE69330809T2 (de) Therapeutisches Agens für Neutropenie
Bichel Chemotherapy in leukemia, Hodgkin's disease, and allied disorders
AR046841A1 (es) Combinaciones para el tratamiento de enfermedades proliferativas
DE10233632A1 (de) Formulierungen von Phenylalanin-Derivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee